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 ABSTRACT 
 Subclinical ketosis (SCK) is defined as concentrations 
of β-hydroxybutyrate (BHBA) ≥1.2 to 1.4 mmol/L and 
it is considered a gateway condition for other metabolic 
and infectious disorders such as metritis, mastitis, clini-
cal ketosis, and displaced abomasum. Reported preva-
lence rates range from 6.9 to 43% in the first 2 mo of 
lactation. However, there is a dearth of information on 
prevalence rates considering the diversity of European 
dairy farms. The objectives of this study were to (1) 
determine prevalence of SCK, (2) identify thresholds 
of BHBA, and (3) study their relationships with post-
partum metritis, clinical ketosis, displaced abomasum, 
lameness, and mastitis in European dairy farms. From 
May to October 2011, a convenience sample of 528 dairy 
herds from Croatia, Germany, Hungary, Italy, Poland, 
Portugal, Serbia, Slovenia, Spain, and Turkey was stud-
ied. β-Hydroxybutyrate levels were measured in 5,884 
cows with a handheld meter within 2 to 15 d in milk 
(DIM). On average, 11 cows were enrolled per farm 
and relevant information (e.g., DIM, postpartum dis-
eases, herd size) was recorded. Using receiver operator 
characteristic curve analyses, blood BHBA thresholds 
were determined for the occurrence of metritis, masti-
tis, clinical ketosis, displaced abomasum, and lameness. 
Multivariate binary logistic regression models were 
built for each disease, considering cow as the experi-
mental unit and herd as a random effect. Overall preva-
lence of SCK (i.e., blood BHBA ≥1.2 mmol/L) within 
10 countries was 21.8%, ranging from 11.2 to 36.6%. 
Cows with SCK had 1.5, 9.5, and 5.0 times greater odds 
of developing metritis, clinical ketosis, and displaced 
abomasum, respectively. Multivariate binary logistic 
regression models demonstrated that cows with blood 
BHBA levels of ≥1.4, ≥1.1 and ≥1.7 mmol/L during 2 
to 15 DIM had 1.7, 10.5, and 6.9 times greater odds of 
developing metritis, clinical ketosis, and displaced ab-
omasum, respectively, compared with cows with lower 
BHBA blood levels. Interestingly, a postpartum blood 
BHBA threshold ≥1.1 mmol/L increased the odds for 
lameness in dairy cows 1.8 (95% confidence interval: 
1.3 to 2.5) times. Overall, prevalence of SCK was high 
between 2 to 15 DIM and SCK increased the odds of 
metritis, clinical ketosis, lameness, and displaced ab-
omasum in European dairy herds. 
 Key words:   prevalence ,  subclinical ketosis , 
 β-hydroxybutyrate ,  postpartum disease 
 INTRODUCTION 
 It is well known that severe negative energy bal-
ance (NEB) in the periparturient period increases the 
risk for postpartum diseases such as retained placenta 
(RP), milk fever, metritis, mastitis, clinical ketosis 
(CK), and displaced abomasum (DA; Dohoo et al., 
1983; Duffield et al., 2009; LeBlanc, 2010). Several 
epidemiological studies have demonstrated that these 
diseases cause major financial losses by increasing di-
agnosis and treatment costs and decreasing milk yield 
and reproductive performance in dairy herds. Approxi-
mately 75% of diseases in dairy cattle occur in the first 
month postpartum (LeBlanc, 2010) and 50% of dairy 
cattle suffer from metabolic and infectious diseases in 
the transition period (LeBlanc, 2010). Therefore, the 
potential of early diagnostic approaches (i.e., rectal 
temperature, vaginal discharge, rumen motility, blood, 
urine or milk ketone bodies, rumen auscultation, and 
percussion) for these diseases has been researched in 
several clinical and epidemiological studies (Dohoo and 
Martin, 1984; Oetzel, 2004; LeBlanc, 2010). 
 The severity and duration of NEB is reflected by 
the increase in circulating NEFA and BHBA and the 
degree of decrease in glucose concentrations (Drackley, 
1999). The decreased DMI prepartum causes NEB 
and increases NEFA and BHBA concentrations (Su-
riyasathaporn et al., 1999; LeBlanc, 2010; Gumen et 
al., 2011). The case definition of subclinical ketosis 
(SCK) is characterized by serum BHBA levels >1.0 to 
1.4 mmol/L in the absence of clinical signs of ketosis 
(Duffield et al., 1998; Iwersen et al., 2009; Rollin et al., 
2010). The highest incidence of SCK occurs within the 
 Prevalence of subclinical ketosis and relationships 
with postpartum diseases in European dairy cows 
 V. S.  Suthar ,*  J.  Canelas-Raposo ,†  A.  Deniz ,† and  W.  Heuwieser *1
 * Clinic for Animal Reproduction, Faculty of Veterinary Medicine, Freie Universität Berlin, Koenigsweg 65, 14163 Berlin, Germany 
%D\HU+HDOWK&DUH$QLPDO+HDOWK$OIUHG1REHO6WUDVVH0RQKHLP*HUPDQ\
 
  
 Received August 6, 2012.
 Accepted January 9, 2013.
  1 Corresponding author:  w.heuwieser@fu-berlin.de 
Open access under CC BY-NC-ND license.
2926 SUTHAR ET AL.
Journal of Dairy Science Vol. 96 No. 5, 2013
first 1 to 3 wk of lactation (Oetzel, 2004; Duffield et 
al., 2009). Most recently, McArt et al. (2012) reported 
an average SCK incidence of 43% (ranging from 26 to 
56%) and described that the peak incidence (28.9%) 
occurred at 5 DIM. Cows from 4 dairy herds (2 in New 
York and 2 in Wisconsin) were each tested for SCK 
6 times at 3, 4, 5, 14, 15, and 16 DIM. It is plausible 
that a more frequent measuring protocol initiated early 
postpartum increases the observed incidence of SCK 
and shifts the time of observed peak incidence to earlier 
in lactation.
Reported prevalence rates range from 8.9 to 43% in 
the first 2 mo of lactation (Dohoo et al., 1983; Duffield 
et al., 1998; McArt et al., 2012). Subclinical ketosis is a 
risk factor for subsequent diseases and has been associ-
ated with metritis, cystic ovarian disease, CK, and DA. 
It has been demonstrated that BHBA concentrations 
exceeding thresholds of 1.1 and 1.6 mmol/L during first 
2 wk after calving were associated with a decreased 
probability of pregnancy and an increased culling risk, 
respectively (Walsh et al., 2007; Duffield et al., 2009; 
Roberts et al., 2012). Odds of developing DA, CK, and 
metritis were 2.6 to 8.0, 3.0 to 6.0, and 1.0 to 5.8 higher, 
respectively, for cows exceeding BHBA concentrations 
of 1.2 to 1.4 mmol/L during the first 2 wk after calving 
(Geishauser et al., 1998; Duffield et al., 2009; Dubuc 
et al., 2010). Chapinal et al. (2012) demonstrated that 
serum BHBA ≥1.4 and ≥1.2 mmol/L during the first 
and second weeks after calving, respectively, were as-
sociated with considerable milk losses (1.5 to 2.4 kg).
Hoeben et al. (1999) and Suriyasathaporn et al. 
(1999) demonstrated in their in vitro studies that severe 
NEB or direct effects of ketones on neutrophils are a 
likely risk factor for postpartum infectious diseases such 
as metritis and mastitis. Therefore, testing for SCK 
during the first 2 wk of lactation could be beneficial 
(Geishauser et al., 1998; Iwersen et al., 2009; LeBlanc, 
2010). The gold standard test for SCK is blood BHBA, 
because it is more stable in blood than acetone or ace-
toacetate (Oetzel, 2004). Recently, an electronic BHBA 
handheld meter (Precision Xtra, Abbott Diabetes Care, 
Abingdon, UK) has been validated for determination of 
BHBA from whole blood in dairy cows (Iwersen et al., 
2009). Considering thresholds of 1.2 and 1.4 mmol/L, 
the sensitivity and specificity of determining SCK were 
88 to 96% and 96 to 97%, respectively. Most studies 
reporting prevalence rates for SCK and its association 
with postpartum infectious and metabolic diseases have 
been conducted in North America. The participating 
research herds included were from Ontario, Canada 
(LeBlanc et al. 2005; Duffield et al., 2009) or New 
York, Pennsylvania, and Vermont in the United States 
(Ospina et al., 2010). These studies reported cow-
level associations of BHBA with health and produc-
tion. Only one study (Chapinal et al., 2011) described 
relationships of selected metabolite concentrations 
with diseases in early lactation considering different 
management systems across 4 regions including the 
Northeast (New York, Ontario), Midwest (Minnesota, 
Wisconsin), Southeast (Florida, Georgia, North Caro-
lina, South Carolina, Virginia), and West (California) 
of North America. There is a dearth of information on 
prevalence of SCK and its association with postpar-
tum diseases considering a wider geographical area and 
more diverse dairy herds, particularly outside North 
America. Therefore, the objectives of this study were to 
(1) determine prevalence of SCK, (2) identify optimum 
thresholds of blood BHBA measured 2 to 15 DIM, and 
(3) study their relationships with the postpartum-relat-
ed diseases metritis, mastitis, CK, DA, and lameness in 
European dairy farms.
MATERIALS AND METHODS
From May to October 2011, a convenience (nonran-
dom) sample of 593 dairy herds located across Croatia, 
Germany, Hungary, Italy, Poland, Portugal, Serbia, 
Slovenia, Spain, and Turkey was studied. The number 
of cows per herd and daily average milk production 
per herd varied from 70 to 2,000 and from 17.5 to 34 
kg/d, respectively. In this study, 98% of the herds kept 
Holstein-Friesian cows, 1.2% kept Holstein-Friesian 
crossbreed, and 0.8% kept Jersey, Brown Swiss, other, 
and crossbreeds of those. Efforts were made to stan-
dardize data collection for participating dairy farms. 
Veterinarians were selected by the technical service 
personnel from Bayer Animal Health (Leverkusen, Ger-
many) and received the same documentation consisting 
of standardized forms to obtain informed consent, to 
collect relevant farm data, and to provide a list with 
definitions of diseases of interest. All veterinarians con-
sented to participate, and the study was approved by 
the Institutional Animal Care and Use Committee of 
Freie Universität Berlin, Germany.
A veterinarian selected the herds at his or her own 
discretion. For consistency, the disease definitions of 
RP (farm personnel diagnosis of failure to pass the fetal 
membranes within 24 h after calving; Duffield et al., 
1998; LeBlanc et al., 2002); milk fever (farm personnel 
or veterinarian diagnosis of stage II or III hypocalcemic 
parturient paresis; Cook et al., 2006); clinical mastitis 
(recorded one or more quarter with visually abnormal 
milk within 30 DIM); metritis (veterinary diagnosis 
based on systemic illness attributed to fetid uterine 
infection before 15 DIM; Duffield et al., 1998); CK (vet-
erinary diagnosis of primary CK based on complaint 
of inappetence or decreased milk production within 
30 DIM, presence of a positive urine or milk ketone 
Journal of Dairy Science Vol. 96 No. 5, 2013
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test, and absence of a DA or other primary disease; 
LeBlanc et al., 2002); DA (veterinary diagnosis of a left 
or right side displacement of the abomasum within 30 
DIM based on auscultation of a characteristic “ping”; 
generally confirmed at surgery; Duffield et al., 1998; 
LeBlanc et al., 2002); and lameness (producer diagnosis 
of undifferentiated lameness within 30 DIM based on 
an abnormal gait or lack of weight bearing on a limb; 
includes diagnosis of interdigital and digital dermatitis; 
Cook et al., 2006) were supplied to the veterinarians 
on information sheets. Veterinarians educated herd 
managers through verbal communication and the in-
formation sheets on case definitions of disease events 
to standardize the information collected. The disease 
information was collected by use of recorded disease 
events on a standard form, on-farm diaries, computer-
recorded events, veterinary visit summaries, and weekly 
visit of the assigned veterinarian.
Cows and heifers were enrolled beginning 10 d be-
fore expected calving date using a list generated from 
herd management software programs, farm diaries, 
and registers. After calving, blood BHBA concentra-
tion (mmol/L) was measured using a handheld me-
ter (Precision Xtra) in whole blood (Iwersen et al., 
2009), and information such as herd milk yield (kg/d) 
and herd size were documented. Farm personnel were 
instructed to document any incident of dystocia, 
twins, RP, milk fever, metritis, mastitis, CK, DA, 
and lameness. Because of a lack in the consistency 
of recording, twins and dystocia were removed from 
analyses. Prevalence of SCK was estimated consider-
ing a blood BHBA threshold of ≥1.2 mmol/L (Rollin 
et al., 2010).
Sample Size
In the present study, a convenience sample of herds 
was utilized as has been done in other studies (Duffield 
et al., 2009; Ospina et al., 2010; Chapinal et al., 2011). 
Initially, we planned random selection of 12 cows per 
herd (Dohoo et al., 2009); however, after removing er-
roneous data because of logistic limitations, a mean 
sample size of 11 cows per herd and a minimum of 280 
cows per country resulted, which is in line with recom-
mendations by Willer (1982). According to Borchardt 
and Staufenbiel (2012), this sample size is also adequate 
for use with variables that have a normal distribution 
or moderate skewness when evaluating the deviation of 
a sample mean from the healthy population mean. In 
this study, a sample size of 11 cows per herd provides 
a moderate risk for type I (α = 0.1) and a marginal 
risk for type II error (β = 0.024) in herd testing for 
metabolic variables.
Inclusion Criteria
Data records of cows were excluded from study if 
blood BHBA concentration was measured before 1 or 
after 15 DIM. Cows with missing records were excluded.
Statistical Analyses
All analyses were performed with MedCalc (version 
12.0.3.0, Schoonjans, Mariakerke, Belgium) and SPSS 
(version 19.0, IBM Inc., IBM-Allee, Ehningen, Ger-
many). Incidence of postpartum diseases, including RP, 
milk fever, metritis, mastitis, CK, DA and lameness, 
and prevalence rate of SCK from 2 to 15 DIM, were 
entered into Excel (Microsoft Corp., Redmond, WA) 
spreadsheets dichotomized (i.e., 0 = without disease, 
1 = with disease). Frequencies of occurrences are pre-
sented to demonstrate descriptive statistics on categori-
cal data.
The concentration of blood BHBA was the main risk 
factor of interest in the assessment of the development 
of postpartum diseases. At this level of analyses, the 
blood BHBA concentrations are presented as continu-
ous variables. Furthermore, incremental 0.1 mmol/L 
cutpoints of BHBA from 0.6 to 2.0 mmol/L were evalu-
ated using dichotomous variables (i.e., 0 for samples 
below a certain cutpoint, 1 for samples above a certain 
cutpoint). All 15 thresholds were evaluated with the 
occurrence of metritis, mastitis, CK, DA, and lameness 
in a univariate binary logistic regression.
To identify optimum thresholds of blood BHBA con-
centration (mmol/L) for the occurrence of postpartum 
diseases as specified (Table 1), we performed receiver 
operator characteristic (ROC) analyses. The ROC 
curves analyze sensitivity and 1 − specificity. Sensi-
tivity is the proportion of animals diagnosed with a 
specified disease that is above an optimum threshold, 
and specificity is the proportion of animals that did 
not have the disease that was below a given thresh-
old (Greiner et al., 2000). The point in an ROC curve 
that is closest to the upper left corner has the highest 
combined sensitivity and 1 − specificity (i.e., Youden 
index) and is considered the optimum threshold for 
that particular postpartum disease. Interpretation of 
this optimum threshold was based on the area under 
the curve (AUC). If the AUC = 0.5, it was considered 
noninformative; if 0.5 < AUC ≤0.7, it was accurate; if 
0.7 < AUC ≤0.9, it was very accurate; if 0.9 < AUC 
<1, it was highly accurate; and if AUC = 1, then it 
was considered perfect (Swets, 1988). Likelihood ratios 
[(LR); = sensitivity/(1 − specificity)] were calculated 
to describe the probability of an animal subsequently 
diagnosed with the postpartum disease of interest hav-
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ing a test result at or above a given cutpoint compared 
with a similar result in an unaffected animal. The LR 
positive (LR+) was the probability that a test result 
at or above the threshold would be more likely to come 
from an animal later diagnosed with the disease.
Univariable binary logistic regression models were 
used to screen the potential cow-level covariates in-
cluding SCK, disease-specific optimum thresholds 
of BHBA, parity (1, 2, 3, and ≥4), months (May to 
October 2011), country (Croatia, Germany, Hungary, 
Italy, Poland, Portugal, Serbia, Slovenia, Spain, and 
Turkey), RP, milk fever, and diseases that occurred be-
fore the disease of interest for their association with the 
5 individual diseases (i.e., metritis, mastitis, CK, DA, 
lameness). Our data set lacked information on DIM of 
first metritis occurrence. At the same time, inclusion of 
metritis in observational studies for disease prediction 
is challenging because of diagnostic difficulties (Shel-
don et al., 2006; Dubuc et al., 2010), limited follow-up 
(Duffield et al., 2009; Ospina et al., 2010), misclassifica-
tion with RP (Sheldon et al., 2006; Ospina et al., 2010), 
and subjective variation (Sheldon et al., 2006; Chapinal 
et al., 2011). Therefore, in this study, overall incidence 
of metritis was offered to the SCK and other disease 
models. For all disease analyses, data were arranged 
such that only data for which blood BHBA measured 1 
d before the disease diagnosis (except metritis) were in-
cluded (Duffield et al., 2009). The interaction between 
potential covariates for the respective diseases was also 
evaluated. The influence of potential interactions on 
disease of interest (P < 0.10) was not determined in 
the univariate logistic model and was removed from 
further analyses.
Variables with P < 0.10 in the initial screening were 
submitted to multivariate binary logistic regression 
models which were built in GENLINMIXED procedure 
of SPSS. Manual backward stepwise elimination proce-
dure was used to eliminate variables from the model. 
Any variable with a significance level of P ≤ 0.05 was 
retained in the model. Considering cow as the experi-
mental unit and herd as a random effect, the disease-
specific screened variables were included in the models. 
Statistical significance was assessed at P ≤ 0.05. The 
scope of this study was to evaluate association of SCK, 
disease-specific optimum thresholds of blood BHBA, 
and their odds of subsequent developing clinical dis-
eases. Therefore, multivariate logistic regression models 
for each clinical disease were built considering SCK and 
disease-specific optimum thresholds separately.
RESULTS
Overall, 6,872 cows from 593 farms were initially 
enrolled (mean: 12; median 8, minimum: 7; maximum: Ta
b
le
 1
. 
P
re
va
le
nc
e 
or
 i
nc
id
en
ce
 o
f 
po
st
pa
rt
um
 d
is
ea
se
s 
in
 5
,8
84
 d
ai
ry
 c
ow
s 
of
 5
28
 h
er
ds
 i
n 
10
 E
ur
op
ea
n 
co
un
tr
ie
s 
C
ou
nt
ry
N
o.
 o
f 
 
he
rd
s
N
o.
 o
f 
 
co
w
s
P
os
tp
ar
tu
m
 d
is
ea
se
1
R
et
ai
ne
d 
 
pl
ac
en
ta
M
ilk
  
fe
ve
r
M
et
ri
ti
s
M
as
ti
ti
s
Su
bc
lin
ic
al
  
ke
to
si
s
C
lin
ic
al
  
ke
to
si
s
L
am
en
es
s
D
is
pl
ac
ed
  
ab
om
as
um
%
N
o.
%
N
o.
%
N
o.
%
N
o.
%
N
o.
%
N
o.
%
N
o.
%
N
o.
It
al
y
66
47
0
15
.3
72
3.
6
17
24
.9
11
7
8.
7
41
36
.6
17
2
11
.1
52
5.
7
27
8.
9
42
C
ro
at
ia
7
28
3
15
.2
43
0
0
3.
2
9
8.
1
23
14
.8
42
1.
4
4
4.
2
12
0.
4
1
H
un
ga
ry
24
27
0
12
.2
33
4.
1
11
13
.3
36
7.
4
20
15
.6
42
0.
4
1
2.
2
6
1.
5
5
P
ol
an
d
11
29
4
9.
5
28
4.
8
14
11
.6
34
7.
0
21
19
.4
57
0.
7
1
4.
8
14
2.
4
7
Se
rb
ia
42
38
4
28
.1
10
8
3.
4
13
18
.5
71
29
.9
11
5
19
.5
75
5.
7
22
10
.4
40
2.
1
8
Sl
ov
en
ia
24
27
1
15
.2
42
4.
1
11
4.
0
11
4.
1
11
24
.0
65
2.
6
7
5.
2
14
1.
1
3
P
or
tu
ga
l
11
3
1,
00
0
8.
3
83
9.
5
95
7.
2
72
4.
6
46
29
.5
29
5
6.
6
66
1.
2
12
4.
6
46
Sp
ai
n
10
0
1,
09
3
8.
1
89
2.
3
25
13
.2
14
4
2.
4
26
22
.5
24
6
2.
5
27
1.
5
16
2.
7
30
G
er
m
an
y
11
7
94
7
6.
4
61
4.
2
40
4.
0
38
1.
8
17
20
18
9
2.
0
19
4.
3
41
1.
0
9
T
ur
ke
y
24
87
2
5.
7
50
0.
9
8
3.
7
32
4.
6
40
11
.2
98
2.
2
19
1.
4
12
1.
1
10
T
ot
al
52
8
5,
88
4
10
.4
60
9
4.
0
23
4
9.
6
56
4
6.
1
36
0
21
.8
1,
28
1
3.
7
21
8
3.
3
19
4
2.
7
16
1
1 P
re
va
le
nc
e 
re
po
rt
ed
 f
or
 s
ub
cl
in
ic
al
 d
ia
gn
os
is
; 
in
ci
de
nc
e 
is
 s
ho
w
n 
fo
r 
al
l 
ot
he
r 
po
st
pa
rt
um
 d
is
ea
se
s.
Journal of Dairy Science Vol. 96 No. 5, 2013
PREVALENCE OF SUBCLINICAL KETOSIS 2929
377 cows/farm). After excluding 988 cows (14.4%) and 
65 herds, a total of 5,884 records from 528 herds of 10 
countries were used for the final analyses. Reasons for 
excluding 10.7 and 3.7% cows (total 14.4%) from analy-
ses were incorrect timing of blood BHBA measurement 
and missing information, respectively. For final SCK, 
metritis, mastitis, CK, lameness, and DA models, 843, 
847, 843, 861, 843, and 472 cows were excluded, re-
spectively, due to a disease event before blood BHBA 
measurement.
Incidence of postpartum diseases including RP, milk 
fever, metritis, mastitis, CK, DA, and lameness and 
the percentage prevalence of SCK by 2 to 15 DIM is 
reported in Table1. The univariate association and de-
tailed test characteristics (i.e., predictive positive and 
negative values, LR+, and sensitivity and specificity of 
serial thresholds of BHBA from 0.6 to 2.0 mmol/L with 
clinical diseases) are demonstrated in Table 2. Univari-
ate models of serial threshold from 0.6 to 2.0 mmol/L 
of BHBA did not reveal a relationship with mastitis (P 
< 0.1; data not shown). Optimum BHBA thresholds of 
≥1.1, ≥1.4, ≥1.7, and ≥1.1 mmol/L were determined 
for the occurrence of CK, metritis, DA, and lameness, 
respectively (P < 0.05; Table 2). The optimum BHBA 
threshold for the occurrence of mastitis was not signifi-
cant (>0.3 mmol/L; P = 0.65). Because RP and milk 
fever occur immediately after parturition, a BHBA 
threshold was not determined.
Subclinical Ketosis
Overall prevalence of SCK using a threshold ≥1.2 
mmol/L of blood BHBA was 21.8%. Maximum and 
minimum prevalence of SCK were 36.6 and 11.2% 
for Italy and Turkey, respectively (Table 1). Eight 
variables—country, months, milk yield (continuous 
variable), parity, RP, milk fever, mastitis, and metri-
tis—were tested in univariate logistic models. Because 
milk yield (P = 0.53) did not meet the inclusion criteria 
(P < 0.10), 7 variables were tested in a multivariate 
logistic regression. Only 5 variables were retained in 
the final logistic model (P < 0.05; Table 3). This model 
suggested that dairy cows suffering from RP and me-
tritis were at risk for subsequent SCK [RP: odds ratio 
(OR) = 1.4, 95% CI: 1.2 to 1.8; metritis: OR = 1.7, 
95% CI: 1.3 to 2.1; Table 3].
Metritis
An optimum threshold of ≥1.4 mmol/L of blood 
BHBA was determined with 28.5% sensitivity and 
84.1% specificity (AUC = 0.6; LR+ = 1.8; P < 0.001). 
Eight variables—country, month, milk yield, parity, 
RP, mastitis, BHBA threshold (below and above 1.4 
mmol/L), and SCK—were tested in univariate logistic 
models. In the final multivariate logistic model, how-
ever, only 4 variables were retained (P < 0.05; Table 
4). The odds of having metritis were 2.5 (95% CI: 1.9 
to 3.1) and 1.7 (95% CI: 1.4 to 2.1) greater in cows 
with RP and SCK, respectively (Table 4). Similar to 
the previous multivariate logistic model with optimal 
threshold (Table 4), the model including SCK indicated 
a 1.5 (95% CI: 1.2 to 1.8) times increased odds of hav-
ing metritis (P < 0.001).
Mastitis
An optimum threshold of ≥0.3 mmol/L of blood 
BHBA was determined with 19.6% sensitivity and 84% 
specificity; however, the association was nonsignificant 
(AUC = 0.5; LR+ = 1.2; P = 0.65). Eight variables—
country, months, milk yield, parity, RP, metritis, 
BHBA threshold (below and above 0.3 mmol/L), and 
SCK—were tested in univariate logistic models. Be-
cause BHBA threshold (≥0.3 mmol/L; P = 0.69) and 
SCK (P = 0.134) did not meet the inclusion criteria 
(P < 0.10), only 7 variables were tested in multivari-
ate logistic regression. In the final multivariate logistic 
model, only 5 variables were retained (P < 0.05; Table 
5). The odds of having mastitis were 2.7 (95% CI: 1.5 
to 2.8; P < 0.001) and 1.6 (95% CI: 1.2 to 2.3; P = 
0.002) greater in cows with RP and metritis, respec-
tively (Table 5).
Clinical Ketosis
An optimum threshold ≥1.1 mmol/L of blood BHBA 
was determined with 81.2% sensitivity and 77.1% speci-
ficity (AUC = 0.84; LR+ = 3.5; P < 0.001; Table 2) for 
the occurrence of CK. For predicting CK, 9 variables—
country, months, milk yield, parity, RP and mastitis, 
BHBA threshold (below and above 1.1 mmol/L), metri-
tis, and SCK—were tested in univariate logistic models. 
Only 5 variables were retained in the final logistic model 
(P < 0.001; Table 6). The odds of having CK were 2.1 
(95% CI: 1.4 to 3.1; P = 0.0003) and 10.5 (95% CI: 7.2 
to 15.3; P < 0.001) greater in cows with metritis and 
optimum threshold ≥1.1 mmol/L, respectively (Table 
6). The model also determined that multiparous cows 
(≥4 parity) had greater odds for development of CK 
(OR = 2.2, 95% CI: 1.4 to 3.5; P < 0.001) compared 
with cows of parity 1, 2, and 3.
Similar to the previous multivariate binary logistic 
model with optimal threshold (Table 6), a model in-
cluding SCK demonstrated 9.5 (95% CI: 6.7 to 13.5) 
times increased odds for subsequently developing CK 
(P < 0.001).
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Table 2. Evaluation of the risk of metritis, clinical ketosis, displaced abomasum, and lameness and univariate association with serum BHBA 
obtained during 2 to 15 DIM after calving in 5,884 dairy cows of 528 herds in 10 European countries 
Disease
Threshold 
(mmol/L)
Cows at or 
above cutpoint
Risk measure1
+PV −PV
Odds 
ratio 95% CI P-value Se Sp LR+
Metritis >0.6 349 11.2 92.3 1.5 1.2–1.8 0.001 61.7 48.4 1.2
>0.7 305 11.5 92.0 1.5 1.3–1.8 0.001 53.9 56.3 1.2
>0.8 269 12.3 92.0 1.6 1.4–1.9 0.010 47.5 64.1 1.3
>0.9 235 12.8 91.9 1.6 1.4–2.0 0.010 41.5 70.1 1.4
>1.0 223 13.2 91.9 1.7 1.5–2.1 <0.0001 39.3 72.7 1.4
>1.1 200 13.4 91.7 1.7 1.5–2.0 <0.0001 35.2 76.0 1.5
>1.2 182 14.2 91.7 1.8 1.5–2.2 <0.0001 32.0 79.5 1.6
>1.3 172 15.1 91.8 2.0 1.6–2.4 <0.0001 30.3 82.1 1.7
>1.42 162 15.9 91.8 2.1 1.8–2.6 <0.0001 28.5 84.1 1.8
>1.5 156 16.0 91.7 2.1 1.7–2.6 <0.0001 27.4 84.8 1.8
>1.6 144 16.1 91.6 2.1 1.7–2.6 <0.0001 25.3 86.1 1.8
>1.7 135 16.2 91.5 2.1 1.7–2.6 <0.0001 23.7 87.1 1.8
>1.8 118 15.6 91.3 2.0 1.6–2.5 <0.0001 20.6 88.2 1.8
>1.9 111 15.8 91.3 2.0 1.5–2.5 <0.0001 19.4 89.1 1.8
>2.0 105 15.6 91.2 1.9 1.6–2.5 <0.0001 18.3 89.5 1.7
Clinical ketosis >0.6 197 11.2 92.3 8.1 5.2–12.6 <0.0001 61.7 48.4 1.2
>0.7 192 11.5 92.0 9.0 6.1–13.5 <0.0001 53.9 56.3 1.2
>0.8 188 12.3 92.0 10.8 7.4–15.8 <0.0001 47.5 64.1 1.3
>0.9 184 12.8 91.9 12.5 8.7–17.9 <0.0001 41.5 70.1 1.4
>1.0 183 13.2 91.9 13.8 9.6–19.8 <0.0001 39.3 72.7 1.4
>1.12 179 12.0 99.1 14.0 10.4–20.7 <0.0001 81.2 77.1 3.6
>1.2 169 13.1 98.9 13.7 9.3–18.8 <0.0001 76.6 80.5 3.9
>1.3 166 14.6 98.9 15.0 10.9–20.6 <0.0001 75.2 83.0 4.4
>1.4 159 15.6 98.7 14.8 10.8–20.0 <0.0001 72.0 85.0 4.8
>1.5 156 16.0 98.7 14.6 10.8–19.6 <0.0001 70.6 85.7 5.0
>1.6 151 16.9 98.6 14.7 10.9–19.8 <0.0001 68.4 87.1 5.3
>1.7 150 18.0 98.6 15.9 11.8–21.3 0.001 67.9 88.1 5.7
>1.8 144 19.1 98.5 16.0 11.9–21.3 0.001 65.1 89.4 6.1
>1.9 144 20.6 98.5 17.7 13.2–23.7 <0.0001 65.1 90.3 6.7
>2.0 141 21.0 98.5 17.5 13.1–23.4 <0.0001 63.8 90.8 6.9
Displaced abomasum >0.6 126 4.0 98.7 3.3 2.3–4.9 <0.0001 78.0 48.1 1.5
>0.7 121 4.5 98.8 3.9 2.7–5.6 <0.0001 74.8 56.2 1.7
>0.8 116 5.2 98.8 4.7 3.2–6.5 <0.0001 71.7 63.9 2.0
>0.9 113 6.1 98.8 5.5 3.9–7.8 <0.0001 69.8 70.1 2.3
>1.0 113 6.6 98.9 6.3 4.5–8.8 <0.0001 69.8 72.7 2.6
>1.1 113 7.5 98.9 7.5 5.3–10.6 <0.0001 69.8 76.2 2.9
>1.2 107 8.3 98.8 7.7 5.6–10.8 <0.0001 66.0 79.6 3.2
>1.3 105 9.2 98.8 8.6 6.2–12.0 <0.0001 64.8 82.1 3.6
>1.4 101 9.9 98.8 8.9 6.5–12.4 <0.0001 62.3 84.2 3.9
>1.5 100 10.2 98.8 9.2 6.6–12.8 <0.0001 61.6 84.9 4.1
>1.6 99 11.0 98.8 10.1 7.3–13.9 <0.0001 61.0 86.3 4.5
>1.72 98 11.7 98.8 10.7 7.6–14.9 <0.0001 60.4 87.4 4.8
>1.8 93 12.2 98.7 10.6 7.7–14.7 <0.0001 57.2 88.6 5.0
>1.9 91 12.9 98.7 11.0 8.0–15.3 <0.0001 56.0 89.5 5.3
>2.0 89 13.1 98.6 11.1 8.0–15.3 <0.0001 54.7 90.0 5.5
Lameness >0.6 121 3.8 97.4 1.5 1.1–2.0 0.010 62.0 47.8 1.2
>0.7 104 3.9 97.2 1.1 1.1–1.9 0.120 53.1 55.6 1.2
>0.8 95 4.3 97.3 1.3 1.3–2.2 <0.0001 48.4 63.3 1.3
>0.9 88 4.7 97.4 1.9 1.4–2.5 <0.0001 44.8 69.5 1.5
>1.0 83 4.8 97.4 1.9 1.4–2.0 <0.0001 42.2 72.0 1.5
>1.12 77 5.1 97.3 2.1 1.5–2.7 <0.0001 39.1 75.4 1.6
>1.2 69 5.3 97.3 2.2 1.5–2.8 <0.0001 34.9 78.8 1.7
>1.3 65 5.6 97.3 2.1 1.6–2.9 <0.0001 32.8 81.3 1.8
>1.4 58 5.6 97.2 2.2 1.5–3.0 <0.0001 29.2 83.3 1.8
>1.5 57 5.7 97.2 2.2 1.7–3.2 <0.0001 28.7 84.0 1.8
>1.6 55 6.0 97.2 2.3 1.4–2.9 <0.0001 27.6 85.5 1.9
>1.7 51 6.0 97.2 2.3 1.6–3.1 <0.0001 25.5 86.5 1.9
>1.8 43 5.5 97.1 2.0 1.4–2.9 <0.0001 21.4 87.7 1.7
>1.9 40 5.5 97.0 2.0 1.4–2.9 <0.0001 19.8 88.5 1.7
>2.0 38 5.4 97.0 2.0 1.4–2.8 0.010 18.8 89.0 1.7
1+PV = positive predictive value; –PV = negative predictive value; Se = sensitivity; Sp = specificity; +LR = positive likelihood ratio.
2Calculated optimal thresholds for each disease (mmol/L).
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Lameness
An optimum threshold of ≥1.1 mmol/L of blood 
BHBA was determined with 39.1% sensitivity and 
75.4% specificity (AUC = 0.6; LR+ = 1.6; P < 0.001) 
for the occurrence of postpartum lameness. For predict-
ing lameness, 9 variables—country, month, milk yield, 
parity, RP, mastitis, BHBA threshold (below and above 
1.1 mmol/L), metritis, and SCK—were tested in uni-
variate logistic models. Milk fever was not associated 
with the occurrence of lameness, (P = 0.395) leaving 
7 covariates for multivariate logistic model. Only 4 
Table 3. Results of multivariate analysis for the identification of risk factors for the development of subclinical ketosis (i.e., cows with blood 
BHBA ≥1.2 mmol/L) in 5,041 dairy cows in 10 European countries 
Covariate Estimate SE P-value
Odds  
ratio
95% CI for odds ratio
Lower Upper
Constant −0.98  <0.001    
Country   <0.001  
 Italy Referent
 Serbia −1.12 0.19 <0.001 0.3 0.2 0.5
 Poland −0.79 0.20 <0.001 0.5 0.3 0.7
 Croatia −1.18 0.22 <0.001 0.3 0.2 0.5
 Slovenia −0.63 0.19 0.001 0.5 0.4 0.8
 Hungary −1.24 0.21 <0.001 0.3 0.2 0.4
 Portugal −0.54 0.13 <0.001 0.6 0.4 0.7
 Spain −0.79 0.13 <0.001 0.5 0.4 0.6
 Germany −0.74 0.16 <0.001 0.6 0.3 0.7
 Turkey −1.97 0.18 <0.001 0.1 0.1 0.2
Metritis (yes) 0.53 0.10 0.001 1.7 1.3 2.1
 no Referent
Retained placenta (yes) 0.37 0.10 <0.001 1.4 1.2 1.8
 no Referent
Parity   <0.001  
 1 Referent
 2 0.17 0.10 0.11 1.2 1 1.5
 3 0.71 0.10 <0.001 2.0 1.6 2.5
 ≥4 0.90 0.10 <0.001 2.5 2.0 3.0
Month   <0.001  
 May 2011 Referent
 June 2011 −0.19 0.12 0.13 0.8 0.6 1.1
 July 2011 −0.37 0.12 <0.001 0.7 0.5 0.9
 August 2011 −0.41 0.13 <0.001 0.7 0.5 0.9
 September 2011 −0.60 0.15 <0.001 0.5 0.4 0.7
Table 4. Results of multivariate analysis for the identification of risk factors for the development of metritis in 5,037 dairy cows in 10 European 
countries 
Covariate Estimate SE P-value
Odds  
ratio
95% CI for odds ratio
Lower Upper
Constant −2.65  <0.001
Country   <0.001
 Italy Referent
 Serbia 0.05 0.19 0.77 0.9 0.6 1.3
 Poland −0.75 0.21 0.21 0.5 0.3 0.8
 Croatia −2.20 0.35 <0.001 0.1 0.1 0.2
 Slovenia −1.93 0.32 <0.001 0.1 0.1 0.3
 Hungary −0.51 0.21 0.015 0.6 0.4 0.9
 Portugal −1.35 0.17 <0.001 0.3 0.2 0.4
 Spain −1.35 0.17 <0.001 0.5 0.4 0.6
 Germany −1.86 0.20 <0.001 0.2 0.1 0.2
 Turkey −1.78 0.22 <0.001 0.2 0.1 0.3
Milk yield (kg/d) 0.04 0.01 0.001 1.1 1.0 1.1
Retained placenta (yes) 0.89 0.12 <0.001 2.5 1.9 3.1
 no Referent
Optimum threshold ≥1.4 mmol/L (yes) 0.51 0.10 <0.001 1.7 1.4 2.1
 no Referent
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variables were retained in the final logistic model (P < 
0.001; Table 7). The odds of having lameness were 1.5 
(95% CI 1.0 to 2.2, P < 0.001) and 1.8 (95% CI 1.3 to 
2.5, P < 0.001) greater in cows with RP and BHBA 
levels above or at 1.1 mmol/L, respectively (Table 7).
Similar to the previous multivariate binary logistic 
model with optimal threshold (Table 7), the model 
including SCK demonstrated 1.8 (95% CI 1.3 to 2.5) 
times increased odds for subsequent occurrence of 
lameness (P < 0.001).
Displaced Abomasum
An optimum threshold of ≥1.7 mmol/L of blood 
BHBA was determined with 60.4% sensitivity and 
87.4% specificity (AUC = 0.76; LR+ = 4.8; P < 0.001) 
for the occurrence of DA. For predicting DA, 12 fac-
tors—country, month, milk yield, parity, RP, milk 
fever, mastitis, BHBA threshold (below and above 
1.7 mmol/L), metritis, lameness, SCK, and CK—were 
tested in univariate logistic models. Plausible factors 
such as milk fever (P = 0.29) and lameness (P = 0.7) 
did not have any influence on the occurrence of DA. 
Therefore, 8 plausible factors remained and were tested 
in the multivariate logistic model. Only 4 variables 
were retained in the final logistic model (P < 0.001; 
Table 8). The odds of having DA were 6.9 (95% CI: 4.9 
to 9.9; P < 0.001) greater in cows with a blood BHBA 
concentration of ≥1.7 mmol/L (Table 8).
Similar to the previous multivariate binary logistic 
model with optimal threshold (Table 8), the model 
including SCK demonstrated 5.0 (95% CI: 3.5 to 7.2) 
times increased odds of subsequent occurrence of DA 
(P < 0.001). Moreover, this model in which CK was 
retained (P < 0.004) demonstrated 1.9 (95% CI: 1.2 to 
33.1) times increased odds of subsequently developing 
DA.
DISCUSSION
The objectives of this study were to (1) determine 
prevalence of SCK, (2) identify optimum thresholds of 
blood BHBA measured 2 to 15 DIM, and (3) study their 
relationships with postpartum-related diseases such as 
metritis, mastitis, CK, DA, and lameness in European 
dairy farms. In this large-scale, multi-regional, observa-
tional study, 5,884 cows of 528 herds from 10 European 
countries were analyzed. Differences in natural re-
sources, cultural traditions, dairy farm structures, and 
market, have caused different regions in the European 
countries to implement different management systems 
(Hemme, 2007). Since 1984, 16 prevalence studies have 
Table 5. Results of multivariate analysis for the identification of risk factors for the development of mastitis in 5,041 dairy cows in 10 European 
countries 
Covariate Estimate SE P-value
Odds  
ratio
95% CI for odds ratio
Lower Upper
Constant −2.70  <0.001
Country   <0.001
 Italy Referent
 Serbia 0.80 0.25 0.001 2.2 1.4 3.7
 Poland −0.33 0.31 0.29 0.7 0.4 1.3
 Croatia −0.14 0.29 0.61 0.9 0.5 1.5
 Slovenia −0.74 0.37 0.04 0.5 0.2 1.0
 Hungary −0.30 0.30 0.31 0.7 0.4 1.3
 Portugal −0.93 0.26 0.0004 0.4 0.2 0.7
 Spain −1.23 0.26 <0.001 0.3 0.2 0.5
 Germany −1.30 0.32 <0.001 0.3 0.1 0.5
 Turkey −1.04 0.26 <0.001 0.4 0.2 0.6
Parity   <0.001
 1 Referent
 2 0.23 0.16 0.15 1.3 0.9 1.7
 3 0.30 0.18 0.09 1.4 0.9 1.9
 ≥4 0.76 0.17 <0.0001 2.2 1.5 3.0
Month       
 May 2011 Referent
 June 2011 −0.44 0.22 0.04 0.6 0.4 1.0
 July 2011 −0.65 0.19 0.0009 0.5 0.4 0.8
 August 2011 −0.22 0.19 0.25 0.8 0.5 1.2
 September 2011 −0.75 0.24 0.002 0.5 0.3 0.8
Metritis (yes) 0.50 0.16 0.002 1.6 1.2 2.3
 no Referent
Retained placenta (yes) 0.73 0.14 <0.0001 2.7 1.5 2.8
 no Referent
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Table 6. Results of multivariate analysis for the identification of risk factors for the development of clinical ketosis in 5,023 dairy cows in 10 
European countries 
Covariate Estimate SE P-value
Odds  
ratio
95% CI for odds ratio
Lower Upper
Constant −6.71  <0.001
Country   <0.001
 Italy Referent
 Serbia 0.45 0.33 0.17 1.6 0.8 3.1
 Poland −1.80 0.62 0.004 0.2 0.0 0.6
 Croatia −1.32 0.54 0.015 0.3 0.1 0.7
 Slovenia −1.00 0.43 0.019 0.4 0.1 0.9
 Hungary −2.64 1.02 0.0098 0.1 0.01 0.5
 Portugal −0.64 0.24 0.010 0.5 0.3 0.9
 Spain −1.44 0.26 <0.0001 0.2 0.1 0.4
 Germany −0.95 0.34 0.005 0.4 0.2 0.8
 Turkey −0.37 0.33 0.26 0.7 0.3 1.3
Metritis   0.0003
 yes 0.75 0.19 0.0001 2.1 1.4 3.1
 no Referent
Milk yield (kg/d) 0.09 0.022 <0.0001 1.1 1.1 1.4
Optimum threshold 
(≥1.1 mmol/L; yes)
2.35 0.19 <0.0001 10.5 7.1 15.2
 no Referent
Parity   0.003
 1 Referent
 2 0.32 0.24 0.17 1.4 0.9 2.3
 3 0.29 0.26 0.23 1.4 0.8 2.2
 ≥4 0.76 0.23 0.001 2.2 1.4 3.5
Month   0.05    
 May 2011 Referent
 June 2011 −0.28 0.25 0.26 0.8 0.5 1.3
 July 2011 −0.27 0.24 0.26 0.8 0.5 1.3
 August 2011 −0.15 0.25 0.05 0.9 0.5 1.5
 September 2011 −0.73 0.34 0.03 0.5 0.2 0.9
Table 7. Results of multivariate analysis for the identification of risk factors for the development of lameness in 5,041 dairy cows in 10 European 
countries 
Covariate Estimate SE P-value
Odds  
ratio
95% CI for odds ratio
Lower Upper
Constant −3.74  <0.001  
Country   <0.001  
 Italy Referent
 Serbia 0.79 0.26 0.002 2.3 1.3 3.8
 Poland −0.05 0.34 0.9 0.9 0.5 1.8
 Croatia −0.09 0.34 0.78 0.9 0.4 1.8
 Slovenia −0.10 0.34 0.76 0.9 0.5 1.8
 Hungary −0.86 0.46 0.06 0.4 0.2 1.0
 Portugal −1.60 0.35 <0.0001 0.2 0.1 0.4
 Spain −1.30 0.32 0.0001 0.3 0.1 0.5
 Germany −0.18 0.26 0.50 0.8 0.5 1.4
 Turkey −1.22 0.36 0.0007 0.3 0.1 0.6
Retained placenta   0.050  
 yes 0.39 0.19 0.047 1.5 1.0 2.2
 no  Referent
BHBA 
(≥1.1 mmol/L; yes) 0.58 0.16 <0.001 1.8 1.3 2.5
 no Referent
Parity   <0.001    
 1 Referent
 2 0.71 0.22 0.001 2.0 1.3 3.2
 3 0.48 0.25 0.06 1.6 1.0 2.7
 ≥4 0.99 0.22 <0.0001 2.7 1.7 4.3
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demonstrated that measuring BHBA in blood (n = 1), 
serum (n = 13), and milk (n = 2) early postpartum 
is associated with other postpartum diseases. Most of 
these studies collected data from dairy herds within a 
20- to 30-km radius of a particular region (LeBlanc et 
al., 2005; Duffield et al., 2009) or were limited to 3 or 4 
neighboring states of the United States (Ospina et al., 
2010). Only one study (Chapinal et al., 2011) demon-
strated relationships between concentrations of energy 
metabolites in the periparturient period and postpar-
tum diseases based on diverse geographical areas within 
North America. A multi-regional study encompassing 
multiple European states investigating prevalence of 
SCK and relationships between blood BHBA concen-
trations early postpartum and postpartum diseases 
has not yet been conducted. This study provides new 
insights into on-farm blood BHBA concentrations 
between 2 and 15 d postpartum and risk factors for 
diseases such as metritis, CK, lameness, and DA.
A recent study that empirically examined a wide 
range of possible cut-off values for BHBA concentra-
tion reported that during the first 2 wk after calving, 
a blood BHBA concentration of ≥1.2 mmol/L was the 
optimum cutpoint for predicting an increased likeli-
hood of adverse health outcomes (Duffield et al., 2009). 
In the second week after calving, the BHBA cutpoint 
on the odds of DA was ≥1.8 mmol/L (OR = 6.22). The 
critical thresholds for BHBA determined in this study 
(CK ≥1.1, DA ≥1.7, metritis ≥1.4, lameness ≥1.1 
mmol/L) were similar to the above range. Furthermore, 
our data support previous reports on associations be-
tween SCK during the first 15 DIM and metritis, CK, 
and DA (LeBlanc et al., 2005; Duffield et al., 2009).
Incidence rates of RP and milk fever in our data 
set were in accordance with previous studies (Dohoo 
and Martin, 1984; LeBlanc et al., 2005; Duffield et 
al., 2009). Because cases of RP or milk fever occurred 
within 24 to 72 h (LeBlanc et al., 2005; Cook et al., 
2006; Duffield et al., 2009) after parturition, their asso-
ciations with blood BHBA were not evaluated. Because 
both diseases have been demonstrated to be potential 
risk factors for postpartum diseases, we did evaluate 
their associations with the 6 postpartum diseases of 
interest. As previously shown, this study suggests that 
multiparous cows have 2.4 (95% CI: 1.8 to 3.1) and 
2.5 (95% CI: 1.4 to 4.3) times greater odds for RP and 
milk fever, respectively, compared with primiparous 
cows (Dohoo and Martin, 1984; LeBlanc et al., 2005; 
Duffield et al., 2009).
The finding of elevated ketone bodies and subsequent 
risk of CK is supported by other studies (Dohoo and 
Martin, 1984; Duffield et al., 2009). The optimum 
BHBA cutpoint based on the maximum total sensitiv-
ity and specificity for CK in this study (≥1.1 mmol/L) 
Table 8. Results of multivariate analysis for the identification of risk factors for the development of displaced abomasum in 5,412 dairy cows 
in 10 European countries 
Covariate Estimate SE P-value
Odds  
ratio
95% CI for odds ratio
Lower Upper
Constant −4.02  <0.001
Country   <0.001
 Italy Referent
 Serbia −0.89 0.45 0.05 0.4 0.2 1.0
 Poland −0.53 0.46 0.25 0.6 0.2 1.5
 Croatia −2.65 1.02 0.009 0.1 0.01 0.5
 Slovenia −1.75 0.61 0.004 0.2 0.1 0.6
 Hungary −1.26 0.50 0.01 0.3 0.1 0.8
 Portugal −0.53 0.25 0.036 0.6 0.4 1.0
 Spain −0.91 0.26 0.0006 0.4 0.3 0.7
 Germany −1.14 0.45 0.011 0.3 0.1 0.8
 Turkey −1.43 0.41 0.0005 0.2 0.1 0.5
Month   0.01
 May 2011 Referent
 June 2011 −0.11 0.25 0.64 0.9 0.5 1.5
 July 2011 −0.26 0.26 0.31 0.8 0.5 1.3
 August 2011 −0.73 0.32 0.02 0.5 0.3 1.0
 September 2011 −1.01 0.42 0.01 0.4 0.2 0.8
BHBA (≥1.7 mmol/L; yes) 1.93 0.18 <0.0001 6.9 4.9 9.9
 no Referent
Parity   <0.001
 1 Referent
 2 0.18 0.27 0.4 1.2 0.7 2.1
 3 0.63 0.26 0.01 1.9 1.1 3.1
 ≥4 0.46 0.26 0.07 1.6 1.0 2.7
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was greater than 1.0 mmol/L serum BHBA (Ospina et 
al., 2010) and lower than in previous reports (≥1.2 to 
≥1.4 mmol/L; Duffield et al., 2009; Seifi et al., 2011). 
However, the reported sensitivity and specificity for the 
identification of an optimum BHBA cutpoint for CK 
was greater in this study (sensitivity 81.2%, specificity 
77.1%) compared with previous studies (Duffield et al., 
2009: first week postpartum: sensitivity 43.7%, speci-
ficity 76.6%, and second week postpartum: sensitivity 
45.0%, specificity 88.4%; Ospina et al., 2010: 3 to 15 
DIM sensitivity 57.0%, specificity 80.0%; Seifi et al., 
2011: first week postpartum: sensitivity 67.7%, specific-
ity 82.2%). Furthermore, the LR+ calculated in this 
study (4.8) for having CK was greater than in previous 
studies (2.75 to 3.14; Duffield et al., 2009; Ospina et 
al., 2010).
The optimum cutpoint of blood BHBA in this study 
for predicting DA was greater than the ≥0.9 to ≥1.4 
mmol/L serum BHBA (LeBlanc et al., 2005; Chapinal 
et al., 2011; Seifi et al., 2011) and lower than ≥1.8 
mmol/L serum BHBA (Duffield et al., 2009). Overall, 
however, our data support evidence of previous reports 
on the association of postpartum BHBA concentrations 
with DA. In the above mentioned studies the odds of 
having DA were 2.9 to 13.6 times greater than in cows 
with BHBA concentrations below the cutpoints. Our 
data generated from 10 European countries with di-
verse management systems and rations confirm these 
odds ratios. In this study, cows with BHBA ≥1.2 or 
≥1.4 mmol/L in the first 15 DIM had 7.8 (95% CI: 5.5 
to 10.8) to 8.9 (95% CI: 6.4 to 12.4) times greater odds 
of having a case of DA than cows with BHBA below 
the cutpoints. The sensitivity and specificity of an op-
timum BHBA cutpoint of our study is in accordance of 
past 5 studies (i.e., LeBlanc et al., 2005; Duffield et al., 
2009; Ospina et al., 2010; Chapinal et al., 2011; Seifi et 
al., 2011). In these studies, the reported sensitivity and 
specificity of an optimum BHBA cutpoint (measured 
during the first 2 wk postpartum) for identification of 
DA were 43.7 to 71% and 69 to 88.4%, respectively.
An increase in BHBA and metritis in this study 
was in accordance with previous studies conducted 
in North America (Dohoo and Martin, 1984; Duffield 
et al., 2009). Such an association between SCK and 
metritis could be due to decreased DMI 1 to 2 wk pre-
partum (Huzzey et al., 2007), increased NEFA pre- and 
postpartum (Duffield et al., 2009; Ospina et al., 2010; 
Chapinal et al., 2011), and subsequent postpartum in-
crease of BHBA (LeBlanc et al., 2005; Duffield et al., 
2009; Chapinal et al., 2011), which has been shown to 
be a risk factor for the occurrence of metritis postpar-
tum. Low availability of glucose and increased NEFA 
and BHBA concentrations have been shown to impair 
several pathways of immune defense in several studies 
(Hammon et al., 2006; Scalia et al., 2006; Graugnard 
et al., 2012). Hammon et al. (2006) reported that cows 
that went on to develop puerperal metritis had a greater 
degree of immunosuppression relative to healthy cows 
as measured by neutrophil function.
The documented prevalence of metritis from stud-
ies conducted in North America and irrespective of 
parity varies widely, from 0.7% (Bruun et al., 2002), 
2.1% (Markusfeld et al., 1997), 2.7% (Duffield et al., 
2009), 7% (Ospina et al., 2010), 21.7% (Hammon et al., 
2006), 16.7% (6.5 to 35.7% depending on the region; 
Chapinal et al., 2011) to 69% (Urton et al., 2005). In 
our study, reported prevalence by country varied from 
3.2% (Croatia) to 24.9% (Italy). We tried to minimize 
erroneous recording of metritis by providing a list with 
disease definitions to the veterinarians. According to 
Sheldon et al. (2006) and similar to the study con-
ducted by Duffield et al. (1998), metritis was defined 
as veterinary diagnosis based on systemic illness (fever 
and inappetence, with or without signs of cardiovascu-
lar compromise) attributable to fetid uterine infection 
before 15 DIM. Poor sensitivity and moderate speci-
ficity of the blood BHBA threshold ≥1.4 mmol/L for 
predicting metritis in this study is in accordance with 
previous studies (sensitivity 28.3 to 63% and specificity 
48 to 83.7%; Duffield et al., 2009; Dubuc et al., 2010; 
Ospina et al., 2010).
An association between SCK (2 to 15 DIM) and 
clinical mastitis (within 30 DIM) postpartum was not 
revealed in our data set. Similarly, Duffield et al. (2009) 
failed to demonstrate an association between incidence 
of clinical mastitis postpartum and BHBA measured 
during the first 2 wk after calving. The recording of 
clinical mastitis may have influenced the association 
with BHBA concentrations measured at 2 to 15 DIM. 
Therefore, we evaluated the association of blood BHBA 
concentration and SCK during 2 to 7 DIM and 8 to 
15 DIM, respectively, with the subsequent occurrence 
of clinical mastitis. However, an association between 
blood BHBA concentration or SCK during 2 to 7 DIM 
(BHBA concentration: P = 0.731; SCK: P = 0.20) and 
8 to 15 DIM (BHBA concentration: P = 0.99; SCK: P 
= 0.587) with clinical mastitis did not exist. Clinical 
ketosis and DA were recorded during the same period 
and were associated with elevated BHBA. The possible 
explanation for this difference might be that CK and 
DA are metabolic disorders and have a direct relation-
ship with NEB (Drackley, 1999). The incidence of clini-
cal mastitis is more influenced by environmental and 
sanitary conditions of the farm (Ruegg, 2003; Kahn 
and Line, 2010). It is well documented that NEB leads 
to immunosuppression and increases susceptibility to 
clinical mastitis (Drackley, 1999). Suriyasathaporn et 
al. (2000) and LeBlanc (2010) reported that SCK in 
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the first 2 wk did not have an association with the inci-
dence of clinical mastitis; however, it increased severity 
and duration of clinical mastitis. The latter was not the 
scope of this study. We hypothesize that the result of 
this study might have been influenced by the diversity 
of the dairy farms, diagnoses from multiple investiga-
tors, environmental conditions, and frequency, timing, 
and method of milking. 
Our data demonstrate that the incidence of postpar-
tum lameness varies from 1.2 to 10.4% (average 3.2%) 
in European dairy herds. This incidence estimate is 
lower than the incidence range of 7 to 34% reported in 
the past (Alban, 1995; Clarkson et al., 1996; Bicalho et 
al., 2008). It is well documented that lameness preva-
lence appears to be affected by several factors such as 
free stall facilities, herd size, regrouping, concrete floor, 
season and regions of cows (Barker et al., 2007, 2010). 
The scope of this article was to evaluate relationships 
of BHBA within 2 to 15 DIM with the occurrence of 
postpartum diseases. Therefore, we did not look at 
the above-mentioned plausible factors. In this study, 
we used the definition of lameness as previously de-
scribed (Cook et al., 2006) as “producer diagnosis of 
undifferentiated lameness within 30 DIM based on an 
abnormal gait or lack of weight bearing on a limb; in-
cludes diagnoses of interdigital and digital dermatitis.” 
We are aware that this definition is broad and does not 
consider the multitude of pathogenetic factors. Because 
of the size of the study, a consistent implementation of 
a gait score (Sprecher et al., 1997) was not feasible. It is 
likely that using a more elaborate diagnostic approach 
would have affected the reported incidence. Neverthe-
less, to the best of our knowledge this is the first large 
data set that has demonstrated that cows with greater 
blood BHBA concentrations during 2 to 15 DIM have 
an increased odds for lameness. Unfortunately, the 
association and pathways between higher BHBA con-
centrations and lameness remain speculative. Our data 
also show a relatively low sensitivity and moderate 
specificity of the BHBA threshold for lameness. This 
might be due to the broad definition of lameness (Cook 
et al., 2006) chosen and the multifactorial nature of 
the disease (Barker et al., 2007, 2010). Both factors 
may have influenced the test characteristics. Our study 
results also support earlier findings from a convenience 
sample of 57 (17 primiparous and 40 multiparous) 
cows from 1 farm (Calderon and Cook, 2011). Inter-
estingly, lame cows had higher BHBA concentrations 
(1.165 mmol/L) than nonlame cows (0.687 mmol/L; 
P < 0.001). Whether lame cows frequented the feed 
bunk less often and consumed less feed and thus were 
at higher risk for SCK or whether SCK was part of the 
etiology of lameness remains speculative. These findings 
warrant further studies to investigate the relationship 
between elevated BHBA concentrations and lameness 
in dairy cows.
Subclinical ketosis early postpartum is a threshold 
disease (Oetzel, 2004) and has significant associations 
with metabolic diseases when BHBA concentrations 
are ≥1.2 mmol/L (Rollin et al., 2010). Interestingly, 
Oetzel (2004) evaluated data from a large field study in 
which BHBA was measured once weekly in early lacta-
tion cows (Duffield et al., 1998) and determined that 
the cumulative incidence of SCK was about 2.2 times 
greater than the average prevalence. This suggests that 
the incidence of ketosis in our study herds was greater 
than 21.8% and could have been up to almost 50%. 
Furthermore, McArt et al. (2012) extrapolated from 
their study that a cow with a blood BHBA concentra-
tion at the high end of SCK range (2.4 mmol/L) is 3 
times more likely to develop a DA and >50 times more 
likely to be removed from the herd.
Overall, odds ratios based on optimal disease-specific 
thresholds of BHBA did not change much when the 
thresholds were slightly varied. Furthermore, the odds 
ratios based on optimal disease-specific thresholds did 
not change much compared with a single threshold of 
≥1.2 mmol/L. These findings support the recommenda-
tion of a universal BHBA threshold (i.e., 1.2 mmol/L) 
for herd evaluations.
For logistical reasons, farm-specific information on 
management and feeding practices was not collected. 
Nevertheless, we speculate that those practices were 
more diverse, based on the agricultural structure 
(Hemme, 2007), than in the sites enrolled in the North 
American studies and that these associations are not 
only prevalent for specific systems but are inherent in 
the dairy industry. All participating veterinarians and 
farmers in this study were educated about each disease 
definition with an information sheet providing defini-
tions for metritis, mastitis, CK, and DA (Duffield et 
al., 1999; LeBlanc et al., 2002) and lameness (Cook 
et al., 2006). Nevertheless, participation of multiple 
investigators, a study design component unavoidable 
for large field trials, and inter-clinician variability 
might have biased the results on associations between 
elevated levels of BHBA and disease occurrence and 
statistical relevance for potential interactions in the 
final multivariate models despite these efforts. Several 
factors might have affected the incidence rates of the 
reported diseases. First, accuracy of diagnoses might 
be different between the diseases. We speculate that 
the diagnosis of DA is more specific than that of lame-
ness. It has been shown that the mean prevalence of 
clinical lameness scored by an independent investiga-
tor was 24.6%, which was 3.1 times greater than the 
prevalence estimated by the herd managers (Espejo et 
al., 2006). Second, one has to keep in mind that the 
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accuracy of implementation of a disease definition and 
the intensity of disease monitoring and documenting 
inherently influence incidence rates. These unavoidable 
factors might have confounded our results as well as 
previous results.
CONCLUSIONS
Prevalence of SCK (blood BHBA ≥1.2 mmol/L) 
is high between 2 and 15 DIM in 10 European coun-
tries. Elevated BHBA concentrations measured with a 
handheld electronic meter on farm within 2 to 15 DIM 
after calving are associated with an increased odds of 
metritis, clinical ketosis, lameness, and displaced ab-
omasum. Odds ratios were highest at disease-specific 
BHBA thresholds for metritis, CK, DA, and lameness. 
However, odds ratios do not change much when a uni-
form threshold of ≥1.2 mmol/L blood BHBA is used. 
Although relevant for research purposes, it is not neces-
sary to use disease-specific thresholds in practice.
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